Lista de obras - Francesco Paolo Russo - Dominio Público Uruguay

A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis

artículo científico publicado en 2004

Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature.

artículo científico publicado en 2017

Adherence in liver transplant recipients.

artículo científico publicado en 2011

Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice

scientific article published on 23 November 2020

Algorithm for prioritization of patients on the waiting list for liver transplantation.

artículo científico publicado en 2007

Bone marrow cells in the liver: Diverse cells, diverse effects

artículo científico publicado en 2007

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma

artículo científico publicado en 2018

Changes in plasma circulating microvesicles in patients with HCV-related cirrhosis after treatment with direct-acting antivirals

scientific article published on 10 September 2019

Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology

artículo científico publicado en 2020

Cost-effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation

artículo científico publicado en 2015

Different neurological outcome of liver transplantation for Wilson's disease in two homozygotic twins.

artículo científico publicado en 2006

Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.

artículo científico publicado en 2009

Donor-Model for End-Stage Liver Disease and Donor-Recipient Matching in Liver Transplantation ⬇️

artículo científico publicado el 1 de mayo de 2011

Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals

artículo científico publicado en 2017

Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation.

artículo científico publicado en 2010

Experimental hepatology applied to stem cells.

artículo científico publicado en 2007

Fibrosis progression and the pros and cons of antiviral therapy for hepatitis C virus recurrence after liver transplantation: a review.

scientific article published on July 2010

Functional and morphological graft monitoring after liver transplantation

artículo científico publicado en 2001

Galectin-3 regulates myofibroblast activation and hepatic fibrosis

artículo científico publicado en 2006

HCV clearance by direct antiviral therapy and occurrence/recurrence of hepatocellular carcinoma: A "true-or-false game".

artículo científico publicado en 2017

Heparanase and macrophage interplay in the onset of liver fibrosis

artículo científico publicado en 2017

Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF)

artículo científico publicado en 2018

Hepatic stem cells: from inside and outside the liver?

artículo científico publicado en 2004

Hepatitis C virus and liver transplantation: where do we stand?

artículo científico

Hepatitis C virus eradication with direct-acting antiviral improves insulin resistance

artículo científico publicado en 2019

Hepatitis C virus infection in end-stage renal disease and kidney transplantation

artículo científico

Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma.

artículo científico publicado en 2007

Histological features of donor grafts for orthotopic liver transplantation

scientific article published on 01 February 2001

Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

artículo científico publicado en 2017

Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting

scientific article published on 01 February 2020

Liver transplantation for viral hepatitis in 2015

artículo científico publicado en 2016

Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors.

artículo científico publicado en 2017

Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis.

artículo científico publicado en 2017

Markers of acute rejection and graft acceptance in liver transplantation

artículo científico publicado en 2015

Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort.

artículo científico publicado en 2017

New Perspectives on Treatment of Hepatitis B Before and After Liver Transplantation.

artículo científico publicado en 2016

Non-invasive risk stratification after HCV-eradication in patients with advanced chronic liver disease

scientific article published on 13 July 2020

Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation

artículo científico publicado en 2019

Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice

artículo científico publicado en 2019

Physiological and clinical implications of proANP(1-98) circulating levels in the perioperative phase of liver transplantation.

artículo científico publicado en 2001

Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics

artículo científico publicado en 2019

Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents.

artículo científico publicado en 2017

Prognostic evaluation of the donor risk index among a prospective cohort of Italian patients undergoing liver transplantation.

artículo científico publicado en 2009

Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study

artículo científico publicado en 2017

Recent advances in understanding and managing liver transplantation

artículo científico publicado en 2016

Reply

artículo científico publicado en 2017

Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation.

artículo científico publicado en 2010

Risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a single-center study

artículo científico publicado en 2015

Risk factors in liver retransplantation: a single-center experience.

artículo científico publicado en 2011

Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease

artículo científico publicado en 2015

Sex-dependent differences in inflammatory responses during liver regeneration in a murine model of acute liver injury

artículo científico publicado en 2017

Skin Cancer and Other Cutaneous Disorders in Liver Transplant Recipients

artículo científico publicado en 2012

Stem and progenitor cells in liver regeneration and repair.

scientific article published on February 2011

Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury.

artículo científico publicado en 2012

The Seville expert workshop for progress in posttransplant lymphoproliferative disorders

artículo científico publicado en 2012

The bone marrow functionally contributes to liver fibrosis

artículo científico publicado en 2006

The sources of parenchymal regeneration after chronic hepatocellular liver injury in mice

artículo científico publicado en 2006

The survival benefit of liver transplantation in hepatocellular carcinoma patients

artículo científico publicado en 2010

Therapeutic application of stem cells in gastroenterology: an up-date

artículo científico publicado en 2011

Timing for treatment of HCV recurrence after liver transplantation: the earlier the better

artículo científico publicado en 2016

Umbilical cord mesenchymal stem cells modulate dextran sulfate sodium induced acute colitis in immunodeficient mice

artículo científico publicado en 2015

Understanding of and attitudes to xenotransplantation: a survey among Italian university students.

artículo científico publicado en 2004

Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience.

artículo científico publicado en 2013

Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis

scientific article published on 15 July 2019

When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review

artículo científico publicado en 2018

Who fares worse after liver transplantation? Impact of donor and recipient variables on outcome: data from a prospective study.

artículo científico publicado en 2013

Lista de obras de Francesco Paolo Russo

A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis

Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature.

Adherence in liver transplant recipients.

Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice

Algorithm for prioritization of patients on the waiting list for liver transplantation.

Bone marrow cells in the liver: Diverse cells, diverse effects

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma

Changes in plasma circulating microvesicles in patients with HCV-related cirrhosis after treatment with direct-acting antivirals

Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology

Cost-effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation

Different neurological outcome of liver transplantation for Wilson's disease in two homozygotic twins.

Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.

Donor-Model for End-Stage Liver Disease and Donor-Recipient Matching in Liver Transplantation ⬇️

Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals

Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation.

Experimental hepatology applied to stem cells.

Fibrosis progression and the pros and cons of antiviral therapy for hepatitis C virus recurrence after liver transplantation: a review.

Functional and morphological graft monitoring after liver transplantation

Galectin-3 regulates myofibroblast activation and hepatic fibrosis

HCV clearance by direct antiviral therapy and occurrence/recurrence of hepatocellular carcinoma: A "true-or-false game".

Heparanase and macrophage interplay in the onset of liver fibrosis

Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF)

Hepatic stem cells: from inside and outside the liver?

Hepatitis C virus and liver transplantation: where do we stand?

Hepatitis C virus eradication with direct-acting antiviral improves insulin resistance

Hepatitis C virus infection in end-stage renal disease and kidney transplantation

Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma.

Histological features of donor grafts for orthotopic liver transplantation

Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting

Liver transplantation for viral hepatitis in 2015

Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors.

Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis.

Markers of acute rejection and graft acceptance in liver transplantation

Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort.

New Perspectives on Treatment of Hepatitis B Before and After Liver Transplantation.

Non-invasive risk stratification after HCV-eradication in patients with advanced chronic liver disease

Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation

Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice

Physiological and clinical implications of proANP(1-98) circulating levels in the perioperative phase of liver transplantation.

Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics

Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents.

Prognostic evaluation of the donor risk index among a prospective cohort of Italian patients undergoing liver transplantation.

Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study

Recent advances in understanding and managing liver transplantation

Reply

Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation.

Risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a single-center study

Risk factors in liver retransplantation: a single-center experience.

Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease

Sex-dependent differences in inflammatory responses during liver regeneration in a murine model of acute liver injury

Skin Cancer and Other Cutaneous Disorders in Liver Transplant Recipients

Stem and progenitor cells in liver regeneration and repair.

Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury.

The Seville expert workshop for progress in posttransplant lymphoproliferative disorders

The bone marrow functionally contributes to liver fibrosis

The sources of parenchymal regeneration after chronic hepatocellular liver injury in mice

The survival benefit of liver transplantation in hepatocellular carcinoma patients

Therapeutic application of stem cells in gastroenterology: an up-date

Timing for treatment of HCV recurrence after liver transplantation: the earlier the better

Umbilical cord mesenchymal stem cells modulate dextran sulfate sodium induced acute colitis in immunodeficient mice

Understanding of and attitudes to xenotransplantation: a survey among Italian university students.

Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience.

Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis

When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review

Who fares worse after liver transplantation? Impact of donor and recipient variables on outcome: data from a prospective study.